Wall Street Zen upgraded shares of Ultralife (NASDAQ:ULBI – Free Report) from a hold rating to a buy rating in a report issued on Thursday.
Ultralife Price Performance
Shares of NASDAQ ULBI opened at $5.53 on Thursday. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04. Ultralife has a fifty-two week low of $4.07 and a fifty-two week high of $12.40. The business has a 50 day moving average price of $4.92 and a two-hundred day moving average price of $6.52. The firm has a market cap of $91.98 million, a PE ratio of 10.05 and a beta of 0.77.
Ultralife (NASDAQ:ULBI – Get Free Report) last released its quarterly earnings results on Friday, May 9th. The technology company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.02). The company had revenue of $50.75 million for the quarter, compared to analyst estimates of $54.50 million. Ultralife had a return on equity of 7.92% and a net margin of 5.44%. During the same period in the previous year, the business posted $0.21 EPS.
Insiders Place Their Bets
Hedge Funds Weigh In On Ultralife
Several large investors have recently added to or reduced their stakes in ULBI. Visionary Wealth Advisors increased its stake in Ultralife by 17.1% during the fourth quarter. Visionary Wealth Advisors now owns 1,292,836 shares of the technology company’s stock valued at $9,632,000 after purchasing an additional 188,384 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Ultralife in the 4th quarter valued at about $522,000. JPMorgan Chase & Co. grew its position in shares of Ultralife by 250.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 47,458 shares of the technology company’s stock valued at $429,000 after buying an additional 33,929 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of Ultralife by 11.6% during the 4th quarter. Renaissance Technologies LLC now owns 256,090 shares of the technology company’s stock valued at $1,908,000 after buying an additional 26,700 shares during the last quarter. Finally, Nuveen LLC acquired a new stake in Ultralife during the first quarter worth about $116,000. 30.68% of the stock is currently owned by institutional investors.
Ultralife Company Profile
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Read More
- Five stocks we like better than Ultralife
- Technology Stocks Explained: Here’s What to Know About Tech
- Turbulence for Joby Shares: What’s Behind the Recent Dip?
- Why Invest in 5G? How to Invest in 5G Stocks
- Why Carnival Could Be the Ultimate Non-Tech Growth Stock
- What to Know About Investing in Penny Stocks
- Super Micro Computer Stock Clears New Path Higher on Saudi Orders
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.